Darwin Global Management, Ltd. Keros Therapeutics, Inc. Transaction History
Darwin Global Management, Ltd.
- $586 Million
- Q1 2024
A detailed history of Darwin Global Management, Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 1,435,950 shares of KROS stock, worth $65.6 Million. This represents 16.21% of its overall portfolio holdings.
Number of Shares
1,435,950
Previous 1,060,427
35.41%
Holding current value
$65.6 Million
Previous $42.2 Million
125.46%
% of portfolio
16.21%
Previous 15.51%
Shares
9 transactions
Others Institutions Holding KROS
# of Institutions
153Shares Held
26.7MCall Options Held
47.6KPut Options Held
34.5K-
Black Rock Inc. New York, NY2.17MShares$99 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$73.1 Million0.18% of portfolio
-
State Street Corp Boston, MA1.56MShares$71.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$70.6 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$58 Million1.89% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.18B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...